当前位置:首页 - 行情中心 - 药康生物(688046) - 财务分析

药康生物

(688046)

  

流通市值:29.20亿  总市值:58.71亿
流通股本:2.04亿   总股本:4.10亿

药康生物(688046)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.98亿元,每股收益0.24元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益212331.42万元,未分配利润43245.48万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产253354.05万元,负债41022.63万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入509,718,216.98340,382,982.48157,087,264.43622,186,991.12
营业总成本414,793,749.59267,437,468.2127,213,613.71486,134,284.8
营业利润99,210,739.4677,417,917.4428,210,897.29163,687,866.16
利润总额99,198,919.0177,410,385.4328,204,594.53161,287,732.53
净利润98,214,378.676,337,717.6429,479,404.17158,914,063.14
其他综合收益-198,986.15138,212.3874,046176,652.84
综合收益总额98,015,392.4576,475,930.0229,553,450.17159,090,715.98
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计1,677,726,535.051,744,108,283.121,648,107,709.61,657,522,891.61
非流动资产合计855,813,951.11870,078,530.51911,323,787.9920,066,986.97
资产总计2,533,540,486.162,614,186,813.632,559,431,497.52,577,589,878.58
流动负债合计341,384,959.63426,643,634.88340,772,915.39366,409,071.83
非流动负债合计68,841,336.474,342,950.0187,430,573.9486,524,362.43
负债合计410,226,296.03500,986,584.89428,203,489.33452,933,434.26
归属于母公司股东权益合计2,123,314,190.142,113,200,228.742,131,228,008.172,124,656,444.32
股东权益合计2,123,314,190.142,113,200,228.742,131,228,008.172,124,656,444.32
负债和股东权益合计2,533,540,486.162,614,186,813.632,559,431,497.52,577,589,878.58
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计420,477,343.76248,372,539.7107,901,546.21627,423,948.94
经营活动现金流出小计436,378,303.47291,937,221.43160,506,283.34510,853,413.43
经营活动产生的现金流量净额-15,900,959.72-43,564,681.74-52,604,737.13116,570,535.51
投资活动现金流入小计1,421,657,306.961,318,968,360.35713,753,844.521,973,187,738.23
投资活动现金流出小计1,368,772,565.081,069,473,029.32643,359,140.591,991,797,521.64
投资活动产生的现金流量净额52,884,741.88249,495,331.0370,394,703.93-18,609,783.41
筹资活动现金流入小计67,950,00067,950,00019,950,00086,000,000
筹资活动现金流出小计172,900,850.8963,866,299.1135,994,111.7346,709,209.61
筹资活动产生的现金流量净额-104,950,850.894,083,700.89-16,044,111.7339,290,790.39
汇率变动对现金及现金等价物的影响-1,355,366.52255,801.36-141,054.211,148,916.53
现金及现金等价物净增加额-69,322,435.25210,270,151.541,604,800.86138,400,459.02
期末现金及现金等价物余额490,670,777.9770,263,364.69561,598,014.01559,993,213.15
最新报告期:2024-11-12
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
华创证券刘浩0.360.450.562024-11-12
国元证券马云涛0.370.460.532024-11-07
华安证券谭国超0.380.480.582024-11-04
开源证券余汝意0.350.460.572024-11-03
国信证券张佳博,马千里0.340.430.532024-10-31
TOP↑